Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway

Exogenous soluble proteins enter the endosomal pathway by endocytosis and are presented in association with MHC class II rather than class I. In contrast, the delivery of exogenous protein antigens (Ag) into the cytosol generates MHC class I‐restricted cytotoxic T lymphocytes (CTL) responses. Althou...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of immunology Vol. 30; no. 6; pp. 1740 - 1747
Main Authors Nakanishi, Tsuyoshi, Hayashi, Akira, Kunisawa, Jun, Tsutsumi, Yasuo, Tanaka, Keiichi, Yashiro‐Ohtani, Yumi, Nakanishi, Mahito, Fujiwara, Hiromi, Hamaoka, Toshiyuki, Mayumi, Tadanori
Format Journal Article
LanguageEnglish
Published Weinheim WILEY‐VCH Verlag GmbH 01.06.2000
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Exogenous soluble proteins enter the endosomal pathway by endocytosis and are presented in association with MHC class II rather than class I. In contrast, the delivery of exogenous protein antigens (Ag) into the cytosol generates MHC class I‐restricted cytotoxic T lymphocytes (CTL) responses. Although several immunization approaches, such as the utilization of liposomes, have induced the in vivo priming of MHC class I‐restricted CTL responses to protein Ag, it remains unclear whether this priming results from the direct delivery of protein Ag to the cytosol. Here we report that fusogenic liposomes (FL), which are prepared by fusing simple liposomes with Sendai virus particles, can deliver the encapsulated soluble protein directly into the cytosol of cells cultured concurrently and introduce it into the conventional MHC class I Ag presentation pathway. Moreover, a single immunization with ovalbumin (OVA) encapsulated in FL but not in simple liposomes results in the potent priming of OVA‐specific CTL. Thus, FL function as an efficient tool for the delivery of CTL vaccines.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0014-2980
1521-4141
DOI:10.1002/1521-4141(200006)30:6<1740::AID-IMMU1740>3.0.CO;2-U